{"id":"W4311575712","doi":"10.1186/s12876-022-02590-6","title":"Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis","year":2022,"lang":"en","type":"article","venue":"BMC Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Tofacitinib; Medicine; Vedolizumab; Adalimumab; Infliximab; Golimumab; Adverse effect; Ulcerative colitis; Number needed to treat; Ustekinumab; Internal medicine; Cost effectiveness; Relative risk; Confidence interval; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002857867,0.0001124235,0.0001764973,0.00003623185,0.00009424505,0.00000101642,0.000110711,0.00004120026,0.0000561616],"category_scores_gemma":[0.00009170233,0.0001180416,0.00007978912,0.00001846212,0.00009657882,0.000004038644,0.0001683267,0.00005205588,2.283105e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000217068,"about_ca_system_score_gemma":0.00007120005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003280717,"about_ca_topic_score_gemma":0.00008386303,"domain_scores_codex":[0.9988884,0.0002996948,0.0002539918,0.0002466619,0.0001073634,0.0002038576],"domain_scores_gemma":[0.9993874,0.00002211883,0.000223411,0.0001894982,0.0001226746,0.00005485692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0279663,0.0002148699,0.4144827,0.0001962069,0.00015289,0.000005299211,0.0005406473,0.00535334,0.5480968,0.00004872183,0.0002335223,0.002708605],"study_design_scores_gemma":[0.008742622,0.004328154,0.9713522,0.00002499771,0.00007574636,0.00004408114,0.001632332,0.001168722,0.01063961,0.00009470685,0.001746404,0.0001504611],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974296,0.00004902567,0.001188393,0.00003171704,0.00009933695,0.0008884433,0.0002903939,0.000004110708,0.00001899402],"genre_scores_gemma":[0.995948,0.00001427109,0.003213209,0.0001424793,0.00002695103,0.0003755791,0.0001533474,0.00001702528,0.0001091984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5568694,"threshold_uncertainty_score":0.4813597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01790258519806624,"score_gpt":0.3036175472860557,"score_spread":0.2857149620879894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}